An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

A Tran-Duy; M Ghiti Moghadam; M Voshaar; HE Vonkeman; A Boonen; P Clarke; G McColl; PM ten Klooster; TR Zijlstra; WF Lems; N Riyazi; EN Griep; Mieke Hazes; R Landewe; HJ Bernelot Moens; P van Riel; M Laar; TL Jansen

doi:10.1002/art.40546

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

A Tran-Duy
, M Ghiti Moghadam
, M Voshaar
, HE Vonkeman
, A Boonen
, P Clarke
, G McColl
, PM ten Klooster
, TR Zijlstra
, WF Lems
, N Riyazi
, EN Griep
, Mieke Hazes
, R Landewe
, HJ Bernelot Moens
, P van Riel
, M Laar
, TL Jansen

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

20 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1557-1564
Number of pages	8
Journal	Arthritis and Rheumatology
Volume	70
Issue number	10
DOIs	https://doi.org/10.1002/art.40546
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1002/art.40546

http://hdl.handle.net/1765/110025

Cite this

Tran-Duy, A., Ghiti Moghadam, M., Voshaar, M., Vonkeman, HE., Boonen, A., Clarke, P., McColl, G., ten Klooster, PM., Zijlstra, TR., Lems, WF., Riyazi, N., Griep, EN., Hazes, M., Landewe, R., Bernelot Moens, HJ., van Riel, P., Laar, M., & Jansen, TL. (2018). An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial. Arthritis and Rheumatology, 70(10), 1557-1564. https://doi.org/10.1002/art.40546

@article{d12fd81fe2384fc7883abec8315ae1c7,

title = "An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial",

author = "A Tran-Duy and \{Ghiti Moghadam\}, M and M Voshaar and HE Vonkeman and A Boonen and P Clarke and G McColl and \{ten Klooster\}, PM and TR Zijlstra and WF Lems and N Riyazi and EN Griep and Mieke Hazes and R Landewe and \{Bernelot Moens\}, HJ and \{van Riel\}, P and M Laar and TL Jansen",

year = "2018",

doi = "10.1002/art.40546",

language = "Undefined/Unknown",

volume = "70",

pages = "1557--1564",

number = "10",

}

Tran-Duy, A, Ghiti Moghadam, M, Voshaar, M, Vonkeman, HE, Boonen, A, Clarke, P, McColl, G, ten Klooster, PM, Zijlstra, TR, Lems, WF, Riyazi, N, Griep, EN, Hazes, M, Landewe, R, Bernelot Moens, HJ, van Riel, P, Laar, M & Jansen, TL 2018, 'An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial', Arthritis and Rheumatology, vol. 70, no. 10, pp. 1557-1564. https://doi.org/10.1002/art.40546

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial. / Tran-Duy, A; Ghiti Moghadam, M; Voshaar, M et al.
In: Arthritis and Rheumatology, Vol. 70, No. 10, 2018, p. 1557-1564.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

AU - Tran-Duy, A

AU - Ghiti Moghadam, M

AU - Voshaar, M

AU - Vonkeman, HE

AU - Boonen, A

AU - Clarke, P

AU - McColl, G

AU - ten Klooster, PM

AU - Zijlstra, TR

AU - Lems, WF

AU - Riyazi, N

AU - Griep, EN

AU - Hazes, Mieke

AU - Landewe, R

AU - Bernelot Moens, HJ

AU - van Riel, P

AU - Laar, M

AU - Jansen, TL

PY - 2018

Y1 - 2018

U2 - 10.1002/art.40546

DO - 10.1002/art.40546

M3 - Article

C2 - 29745059

SN - 2326-5191

VL - 70

SP - 1557

EP - 1564

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

IS - 10

ER -

Tran-Duy A, Ghiti Moghadam M, Voshaar M, Vonkeman HE, Boonen A, Clarke P et al. An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial. Arthritis and Rheumatology. 2018;70(10):1557-1564. doi: 10.1002/art.40546